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Youden’s test is a reliable method to evaluate the robustness of analytical methods, by means of an 
experiment design which involves seven analytical parameters combined in eight tests. In the present 
study, we assessed the robustness of a chromatographic method to quantify lumefantrine in raw material 
samples, using Youden’s test. Hence, it was possible to determine the effect of each analytical parameter 
in the final analysis results. Youden’s test showed to be a simple and feasible procedure to evaluate the 
robustness of chromatographic methods.
Uniterms: Lumefantrine/determination. Youden’s test. High Performance Liquid Chromatography/
quantitative analysis. 
O teste de Youden constitui um método confiável para avaliação da robustez de métodos analíticos, por 
meio de um delineamento que envolve sete parâmetros analíticos combinados em oito experimentos. 
No presente estudo, a robustez de um método cromatográfico para quantificação de lumefantrina em 
matéria-prima farmacêutica foi avaliada utilizando-se o teste de Youden. Assim, foi possível determinar 
o efeito de cada parâmetro analítico nos resultados finais das análises. O teste de Youden se mostrou um 
procedimento simples e confiável para a avaliação da robustez de métodos cromatográficos.
Unitermos: Lumefantrina/determinação. Teste de Youden. Cromatografia Líquida de Alta Eficiência/
análise quantitativa.
INTRODUCTION
In pharmaceutical analysis, often an intensive 
method validation is required, in order to meet the strict 
regulations set by the regulatory authorities. In this con-
text, nowadays, robustness testing is gaining interest and 
becoming increasingly more important. In the past, these 
tests were often not performed due to their complexity, to 
the many possible experimental set-ups (usually by expe-
rimental designs) and analysis methods, and also due to 
the lack of guidelines (Dejaegher, Heyden, 2007).
The robustness of an analytical method is the me-
asure of its capacity to remain unaffected by small, but 
deliberate variations in method parameters, and provides 
an indication of its reliability during normal usage. The 
robustness of a chromatographic method, for example, 
may be evaluated by variations in parameters such as 
mobile phase composition, pH and ionic strength, tem-
perature and different lots or suppliers of columns (ICH, 
1996; Brasil, 2003; The United States Pharmacopoeia, 
2007). The evaluation of robustness should be conside-
red during the method development phase. In fact, the 
process of validating a method cannot be separated from 
the actual development of the method conditions, since 
it is not possible to know whether the method conditions 
are acceptable until validation studies are performed. The 
development and validation of a new analytical method 
may therefore be an interative process (Green, 1996).
The evaluation of the robustness of chromatographic 
methods often is complex and laborious, taking into account 
the large number of analytical parameters that should be 
considered to carry out the test. Some authors select specific 
analytical parameters to be evaluated, introducing small 
variations in the nominal conditions and the statistical 
interpretation is performed by means of Student’s t-test or 
ANOVA test (Dejaegher, Heyden, 2007).
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Other wider alternative to determine the robustness 
of analytical methods is the Youden’s test. This test allows 
not only evaluating the method robustness but also poin-
ting out the influence of each analytical parameter in the 
final results. The basic idea of Youden’s test is not to study 
one alteration at time but to introduce several changes at 
once, in such a manner that the effects of individual chan-
ges can be ascertained (Youden, Steiner, 1975; Inmetro, 
2003). 
In the Youden’s test, seven analytical parameters are 
selected to be evaluated and eight runs are carried out in a 
factorial combination to determine the influence of each 
parameter in the final result. The runs are performed with 
the analytical conditions at their nominal value and with 
a slight variation (Youden e Steiner, 1975; INMETRO, 
2003). If measurements are susceptible to variations in 
analytical conditions, these conditions should be suitably 
controlled or a precautionary statement should be included 
in the procedure, aiming to control and to monitor these 
variations (ICH, 1996; Brasil, 2003). 
The aim of the work was to evaluate the robustness 
of the chromatographic method for the quantitation of 
lumefantrine, using Youden’s test, and determine the 
analytical parameters that present higher influence in the 
final results of the analysis.
Lumefantrine is an antimalarial widely used in ma-
laria endemic areas (Figure 1), generally associated with 
artemether, in fixed dose combination tablets. 
Many studies have demonstrated that this asso-
ciation is highly effective in the treatment of resistant 
P. falciparum malaria, resulting in high cure rates and 
prevention against reinfection (Bakshi et al., 2000; Mar-
tensson et al., 2005; Sutherland et al., 2005). Nowadays, 
the lumefantrine-artemether association is the first line 
therapy recommended by Brazilian Health Ministry to the 
falciparum malaria treatment (Brasil, 2006). 
Some studies available in the literature describe the 
quantitation of lumefantrine by HPLC with UV detection, 
in plasma or blood (Mansor et al., 1996; Annerberg et 
al., 2005; Lindegardh et al., 2005) and in pharmaceutical 
products (César et al., 2008). At the present work, the ro-
bustness of a chromatographic method for the quantitation 
of lumefantrine in raw materials was evaluated by means 
of Youden’s test.
MATERIALS AND METHODS
Reagents and materials
Lumefantrine chemical reference substance and raw 
material were purchased from Dafra Pharma (Turnhout, 
Belgium). Methanol, trifluoroacetic acid and dichlorome-
thane (HPLC grade) were purchased from Tedia (Fairfield, 
OH, USA). Water was purified using a Millipore system 
(Bedford, MA, USA).
Chromatographic conditions
The HPLC analyses were carried out on Agilent 
1200 and HP 1100 systems (Palo Alto, CA, USA), both 
composed of quaternary pump, autosampler, diode array 
detector (DAD) and HP ChemStation software. The co-
lumns used were Symmetry C18 (250 x 4.6 mm i.d.; 5 µm 
particle size) from Waters, and Ace C18 (250 x 4.6 mm i.d.; 
5 µm particle size) from ACT, both maintained at 30 °C. 
The mobile phase consisted of methanol and trifluoroa-
cetic acid 0.05% (v/v) (80:20), pH 2.8, at a flow rate of 1 
ml/min. The detection was performed at 335 nm and the 
injection volume was 20 µl.
Preparation of lumefantrine standard and sample 
solutions
Standard solution: approximately 15 mg of lume-
fantrine reference standard were accurately weighed and 
transferred to a 50 ml volumetric flask. An aliquot of 1 ml 
of dichloromethane was added to ensure the complete so-
lubilization and the volume was completed with methanol. 
An aliquot of 4 ml of the obtained solution was transferred 
to a 50 ml volumetric flask and the volume was adjusted 
with mobile phase, so that the final concentration was 24 
µg/ml.
Sample solution: approximately 30 mg of lumefan-
trine raw material were accurately weighed and transferred 
to a 100 ml volumetric flask. An aliquot of 2 ml of dichlo-
romethane was added to ensure the complete solubilization 
and the volume was completed with methanol. An aliquot 
of 4 ml of the obtained solution was transferred to a 50 ml 
FIGURE 1 – Lumefantrine chemical structure.
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volumetric flask and the volume was adjusted with mobile 
phase. 
Robustness evaluation by means of Youden’s test
The robustness evaluation of the chromatographic 
method for the lumefantrine quantitation was performed 
using the method proposed by Youden e Steiner (1975). 
Seven analytical parameters were selected and small va-
riations were induced in the nominal values of the method. 
Then, eight runs were performed aiming to determine the 
influence of each parameter in the final result. The seven 
analytical parameters employed, as well as the introduced 
variations are demonstrated at Table I. The analytical 
conditions at the nominal values are represented by capi-
tal letters and the conditions with the small variation are 
represented by lowercase letters.
The seven parameters and its respective variations 
were combined in eight assays or chromatographic runs, 
performed in a random order. Table II demonstrates the 
factorial combination of the parameters for the Youden’s 
test. The analyses results are shown by letters from s to 
z. Hence, when combination 1 was assayed, the obtained 
result was s. When combination 2 was assayed, the obtai-
ned result was t, and so successively. 
In each combination, three injections of each sam-
ple and standard solutions were carried out, at the work 
concentration (24 µg/ml). After the change of chroma-
tographic column or mobile phase composition, 30 min 
were awaited for system stabilization. The evaluated re-
sults in each combination were peak area, retention time 
(Rt), tailing factor (T), theoretical plates number (N) and 
lumefantrine content.
To determine the influence of variations of each 
parameter in the final result, the mean of the four values 
corresponding to the capital letters (nominal conditions) 
was compared to the mean of the four values correspon-
ding to the lowercase letters (altered conditions). For 
example, to evaluate the effect of the column temperature 
in the final result of the analyses, the following equation 
was employed:
 Eq. (1)
Thus, the influence of the seven analytical parameters 
regarding the peak area, retention time (Rt), tailing factor 
TABLE I – Analytical parameters and variations for the robustness evaluation of the chromatographic method for lumefantrine 
quantitation
Parameter Nominal condition Variation 
A/a Methanol concentration in mobile phase  80%   - A   77% - a
B/b Mobile phase pH 2.8 - B   3.1 - b
C/c Column temperature 30 °C - C   35 °C - c
D/d Mobile phase flow rate 1.0 - D  1.2 - d
E/e Column supplier Symmetry - E   Ace - e
F/f Methanol supplier Tedia - F  J.T. Baker - f
G/g Chromatograph model Agilent 1200 - G   HP 1100 - g
TABLE II – Factorial combination of the analytical parameters for robustness evaluation by Youden’s test
Analytical parameter Factorial combination
1 2 3 4 5 6 7 8
Methanol concentration A A A A a a a a
Mobile phase pH B B b b B B b b
Column temperature C c C c C c C c
Mobile phase flow rate D D d d d d D D
Column supplier E e E e e E e E
Methanol supplier F f f F F f f F
Chromatograph model G g g G g G G g
Result s t u v w x y z
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(T), theoretical plates number (N) and lumefantrine content 
were evaluated. By means of Youden’s test, it is possible 
to establish certainly the parameters which present higher 
influence in the final result of the analyses and perform a 
more rigorous control in the eventual variations of these 
parameters that may occur during a routine analysis.
RESULTS AND DISCUSSION
The assays for the robustness evaluation of the 
chromatographic method were carried out simultaneously 
in both equipments, Agilent 1200 e HP1100. A Symmetry 
column was initially tested in Agilent 1200 chromatogra-
ph, while the analyses were performed with Ace column 
at HP1100 chromatograph. Afterward, the columns were 
changed in the equipments. 
The results obtained in the eight runs to the lume-
fantrine sample and standard solutions are demonstrated 
in Table III. The values presented in the table represent the 
average of three injections of each solution.
To evaluate the effect of each parameter, the average 
of the four values corresponding to altered conditions was 
subtracted from the average of the four values obtained at 
the nominal conditions, as demonstrated in Eq. (1). The 
effects of the parameter variations in the analysis results 
are presented in Table IV.
Using the criteria of Youden’s test, the chromato-
graphic method showed to be highly robust regarding the 
TABLE III – Results obtained in eight runs performed for robustness evaluation, for lumefantrine sample (Sam.) and standard 
(Stan.) solutions
Condition Area Retention time Tailing factor N Content (%)
Sam. Stan. Sam. Stan. Sam. Stan. Sam. Stan.
1 858 839 4.91 4.40 1.06 0.94 4730 4433 99.63
2 876 855 6.71 6.67 1.95 1.92 5254 5276 99.80
3 727 709 3.89 3.89 1.04 1.04 3924 3927 99.85
4 719 703 5.63 5.61 2.57 2.56 3433 3418 99.63
5 726 711 10.26 10.25 1.92 1.90 5350 5456 99.48
6 710 694 5.66 5.60 1.09 1.09 4509 4403 99.64
7 857 838 12.27 11.75 2.54 3.00 5056 3598 99.60
8 870 852 4.55 4.40 1.05 1.02 5020 4467 99.51
TABLE IV – Effects of the analytical parameters in content, retention time (Rt), tailing factor (T) and theoretical plates number (N) 
of the chromatographic method for lumefantrine quantitation
Effect Content (%)* Rt (min)* Tailing factor* N*
Methanol concentration 
(A = 80%; a = 77%)
99.73 – 99.56 = 0.17 5.14 – 8.00   = -2.86 1.62 – 1.75   = -0.14 4263 – 4481 = -218
Mobile phase pH 
(B = 2.8; b = 3.1)
99.64 – 99.65 = -0.01 6.73 – 6.41   = 0.32 1.46 – 1.90   = -0.44 4892 – 3853 = 1039
Column temperature 
(C = 30 °C; c = 35 °C)
99.64 – 99.65 = -0.01 7.57 – 5.57   = 2.00 1.72 – 1.65   = 0.07 4353 – 4391 = -38
Mobile phase flow rate 
(D = 1.0 ml/min; d = 1.2 ml/min)
99.64 – 99.65 = -0.01 6.81 – 6.34   = 0.47 1.72 – 1.65   = 0.07 4443 – 4301 = 142
Column supplier 
(E = Symmetry, e = Ace)
99.66 – 99.63 = 0.03 4.57 – 8.57   = -4.00 1.02 – 2.34   = -1.32 4308 – 4437 = -129
Methanol supplier 
(F = Tedia; f = J.T. Baker)
99.56 – 99.72 = -0.16 6.17 – 6.98   = -0.81 1.61 – 1.76   = -0.16 4443 – 4301 = 142
Chromatograph model 
(G = Agilent 1200; g = HP1100)
99.63 – 99.66 = -0.03 6.84 – 6.30   = 0.54 1.90 – 1.47   = 0.43 3963 – 4782 = -819
* Average of the values obtained at nominal conditions – average of the values obtained at altered conditions.
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lumefantrine content, when variations in seven analytical 
parameters were introduced. The highest variation in 
the lumefantrine content was 0.17%, when the concen-
tration of methanol in the mobile phase was altered; a 
value considerably low and not significant in routine 
analyses.
The retention time of lumefantrine peak was more 
considerably influenced by three analytical parameters. 
The decrease of the methanol concentration reduced the 
eluent strength of the mobile phase and induced the in-
crease of the retention time of the lumefantrine peak. The 
change of column supplier promoted the same effect. In 
spite of both columns possess the same stationary phase 
(octadecyl silane chemically bonded to silica) and the 
same length (250 mm), changes in the supplier or even 
in the batch of the columns may result in significant alte-
rations in the stationary phase selectivity. In addition, the 
change of the column supplier promoted also an increase 
of the tailing factor, due to the selectivity alteration and 
band broadening that is observed with the increase of 
retention time.
The increase of column temperature from 30 °C to 
35 °C induced a reduction of 2 minutes in the retention 
time of the lumefantrine peak. In this case, a special care 
must be taken, since the combination of high temperatu-
res with pH values close to the work limits of the column 
(such as pH 2.8) may reduce its useful life due to the silica 
hydrolysis in the stationary phase.
The apparent pH of the mobile phase presented 
considerable effect in the peak tailing factor. The use of a 
mobile phase with apparent pH of 2.8 assures the comple-
te ionization of lumefantrine, which is a weak base. The 
increase of the mobile phase pH may alter the ionization, 
so that the analyte will be partially non ionized, resulting 
in peak tailing. The chromatograph model was another 
parameter that demonstrated influence on tailing factor. 
This fact may be due to a dead volume in the connections 
between the equipment modules.
The number of the theoretical plates is a parame-
ter that takes into account the retention time, as well as 
the band broadening of the analyte peak. High retention 
times and low band broadening provide an elevate colu-
mn efficiency. Thus, it was possible to observe a direct 
correlation between the theoretical plates number and the 
retention time and tailing factor in the results of Table IV. 
The increase of the apparent pH of the mobile phase, for 
example, promoted an increase in the tailing factor and 
consequently a significant decrease in the theoretical plates 
number, indicating reduction of the column efficiency. The 
change of the chromatograph model presented the inverse 
effect, i.e., tailing factor decrease and so, increase of the-
oretical plates number. The alteration of column supplier 
did not promote significant variations in the theoretical 
plates number, probably because the increase of the tailing 
factor was compensated by the considerable increase of 
the retention time. 
Some parameters such as mobile phase flow rate and 
methanol supplier presented low influence in the evaluated 
factors of the chromatographic method.
CONCLUSION
Youden’s test showed to be a reliable and useful 
tool for the robustness evaluation of the chromatographic 
method for lumefantrine quantitation in raw material. 
By means of this test, it was possible to evaluate the 
effect of seven analytical parameters in the final result 
of the analyses, performing only eight runs. Therefore, 
Youden’s test can be successfully applied for the ro-
bustness evaluation in validation process of analytical 
methods by HPLC.
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